FHB
ONCT

First Hawaiian Bank’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

First Hawaiian Bank’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1
Closed – – 1571
2019
Q1 		$0 Hold
1
– – ﹤0.01% 1855
2018
Q4 		$0 Hold
1
– – ﹤0.01% 1907
2018
Q3 		$0 Buy
+1
New +$2.4K ﹤0.01% 1837

Other funds holding ONCT

AAM
Aureus Asset Management Boston, Massachusetts $1.5B AUM 20.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Cohen Capital Management Corte Madera, California $735M AUM 36.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Hawaiian Bank's ONCT Position: Q2 2019 in Review

First Hawaiian Bank sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2019, closing a stake of 1 share.

First Hawaiian Bank first reported a position in ONCT in Q3 2018 and held it in 3 quarters. The position peaked at $0 in Q1 2019. 24 funds tracked by Wall St. Rank hold ONCT as of Q2 2019.

  • First Hawaiian Bank reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • First Hawaiian Bank sold 1 Oncternal Therapeutics, Inc. Common Stock share in Q2 2019.
  • First Hawaiian Bank first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
  • First Hawaiian Bank's Oncternal Therapeutics, Inc. Common Stock position peaked at $0 in Q1 2019.
  • 24 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.